Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript

May 24, 2023 / 03:05PM GMT
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst

Thank you. Good morning, everyone. My name is Gena Wang. I'm (inaudible) biotech analyst at the Barclays. Welcome to our seventh gene editing, gene therapy summit. It is really great to have this happened again. I wanted to take this opportunity to thank all the investors companies, and also especially our event team and the corporate access team who made this event possible. With that, I would like to introduce our next presenting company, Beam Therapeutics. With us today, we have John Evans, Chief Executive Officer. John, thank you very much for giving us this opportunity.

John M. Evans - Beam Therapeutics Inc. - CEO & Director

Thank you for having me.

Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst

Yes. So maybe before we dive into the specific questions, do you want to give a quick overview.

John M. Evans - Beam Therapeutics Inc. - CEO & Director

Sure. Yes. So Beam

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot